Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Immune Thrombocytopenia (ITP) Immune-Genetic Assessment (UNIT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2010 by Azienda Ospedaliero Universitaria Udine, SOC Clinica Ematologica.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Azienda Ospedaliero Universitaria Udine, SOC Clinica Ematologica
ClinicalTrials.gov Identifier:
NCT01196884
First received: September 7, 2010
Last updated: September 8, 2010
Last verified: September 2010
  Purpose

Primary ITP has wide heterogenous biology, presentation and response to therapy.

The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.


Condition
Thrombocytopenia

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: IMMUNE-GENETIC ASSESSMENT OF PRIMARY ITP IN ADULT

Resource links provided by NLM:


Further study details as provided by Azienda Ospedaliero Universitaria Udine, SOC Clinica Ematologica:

Estimated Enrollment: 190
Study Start Date: September 2010
Groups/Cohorts
Asymptomatic ITP patients
ITP patients treated with Rituximab
ITP patients treated with steroids

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Primary care clinic

Criteria

Inclusion Criteria:

  • Adult patients with primary ITP

Exclusion Criteria:

  • Secondary ITP
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01196884

Contacts
Contact: Francesco Zaja, MD +39 0432 559604 zaja.francesco@aoud.sanita.fvg.it

Locations
Italy
Istituto di Ematologia L. & A. Seragnoli Not yet recruiting
Bologna, Italy, 40100
Contact: Nicola Vianelli, MD         
Department of Hematology and Bone Marrow Transplantation Unit, Oncology Center Armando Businco Not yet recruiting
Cagliari, Italy, 09100
Contact: Emilio Usala, MD         
UF Ematologia, Policlinico di Careggi Not yet recruiting
Firenze, Italy
Contact: Antonella Gozzini, MD         
Department of Oncology/Haematology, Niguarda Ca'Granda Hospital Not yet recruiting
Milano, Italy
Contact: Silvia Cantoni, MD         
U.O. Ematologia 2, IRCCS Cà Granda Ospedale Maggiore Policlinico Not yet recruiting
Milano, Italy, 20122
Contact: Wilma Barcellini, MD         
Clinica Ematologica, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi del Piemonte Orientale "Amedeo Avogadro Not yet recruiting
Novara, Italy, 28100
Contact: Gianluca Gaidano, Prof.         
Istituto di Immunologia, Dipartimento di Scienze Mediche dell'Università degli Studi del Piemonte Orientale "Amedeo Avogadro" Not yet recruiting
Novara, Italy, 28100
Contact: Umberto Dianzani, Prof.         
Department of Medical and Surgical Sciences, University of Padova Not yet recruiting
Padova, Italy, 35100
Contact: Fabrizio Fabris, Prof.         
Oncology-Hematology Department, "S. Maria delle Croci" Hospital Not yet recruiting
Ravenna, Italy, 48121
Contact: Alfonso Zaccaria, MD         
Institute of Hematology, Catholic University, Not yet recruiting
Roma, Italy, 00168
Contact: Valerio De Stefano, MD         
Ematologia, Ospedale Ca' Foncello Not yet recruiting
Treviso, Italy, 31100
Contact: Filippo Gherlinzoni, MD         
Clinica Ematologica AOUD S. Maria Misericordia Not yet recruiting
Udine, Italy, 33100
Contact: Francesco Zaja, MD    +39 0432559604    zaja.francesco@aoud.sanita.fvg.it   
Principal Investigator: Francesco Zaja, MD         
Ematologia, San Bortolo Hospital Not yet recruiting
Vicenza, Italy, 36100
Contact: Francesco Rodeghiero, Prof.         
Sponsors and Collaborators
Azienda Ospedaliero Universitaria Udine, SOC Clinica Ematologica
  More Information

No publications provided

Responsible Party: Francesco Zaja, Clinica Ematologica, Azienda Ospedaliero Universitaria S. Maria Misericordia di Udine
ClinicalTrials.gov Identifier: NCT01196884     History of Changes
Other Study ID Numbers: UNIT
Study First Received: September 7, 2010
Last Updated: September 8, 2010
Health Authority: Italy: Ministero della Salute

Keywords provided by Azienda Ospedaliero Universitaria Udine, SOC Clinica Ematologica:
Patients with primary Immune Thrombocytopenia (ITP)

Additional relevant MeSH terms:
Thrombocytopenia
Blood Platelet Disorders
Hematologic Diseases

ClinicalTrials.gov processed this record on November 20, 2014